Clinical Trials in Atlanta

Showing 7561-7580 of 19,805 trials

Omnipod Horizon™ Automated Glucose Control System Preschool Cohort

NCT04476472

Subjects will undergo a 14-day outpatient, standard therapy phase during which sensor and insulin data will be collected. This will be followed by a 94-day (13-week) hybrid closed-loop phase conducted in an outpatient setting, and an optional 12-month extension phase.

Type 1 Diabetes Mellitus

Insulet Corporation80 participantsStarted Sep 2020

Palo Alto, California, United States • Denver, Colorado, United States • New Haven, Connecticut, United States +7 more locations

COMPLETEDPhase 2< 1 mile

A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia

NCT04849988

This Phase 2 trial will evaluate the safety and efficacy of ABP-450 for the treatment of cervical dystonia in adults. The study will enroll 60 patients across approximately 30 sites in the United States. Study subjects will be divided evenly across a low dose group, a medium dose group, a high dose group, and a placebo group for one treatment cycle.

Cervical Dystonia

AEON Biopharma, Inc.61 participantsStarted Mar 2021

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Fountain Valley, California, United States +18 more locations

Omnipod Horizon™ Automated Glucose Control System Preschool Cohort

A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia

Find Trials by Condition in Atlanta

Open-label Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD

A Study of ABBV-011 Alone and in Combination With Budigalimab (ABBV-181) in Participants With Relapsed or Refractory Small Cell Lung Cancer

Actuate 1901: 9-ING-41 in Myelofibrosis

S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer

The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease

Lung EpiCheck Biomarkers Development Study

A Study of AL101 Monotherapy in Patients With Notch Activated Triple Negative Breast Cancer

PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

A Study of H3B-8800 (RVT-2001) in Participants With Lower Risk Myelodysplastic Syndromes

Home Pulmonary Rehabilitation for COPD

A Study to Assess the Pharmacokinetics of Certolizumab Pegol in Adults With Active Rheumatoid Arthritis

Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor

Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes

DS-6157a in Participants With Advanced Gastrointestinal Stromal Tumor (GIST)

A Study to Assess Safety and Tolerability of CC-486 (ONUREG®, Oral Azacitidine) in Combination Therapy in Participants With Acute Myeloid Leukemia (AML)

Adjunctive Vortioxetine in Schizophrenia

Study Comparing Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy (CRT) for Spinal Metastases

Study to Assess the Safety and Efficacy of Viltolarsen in Ambulant Boys With DMD (RACER53-X)